Foresite Capital Management II as of Sept. 30, 2017
Portfolio Holdings for Foresite Capital Management II
Foresite Capital Management II holds 12 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aimmune Therapeutics | 38.4 | $95M | 3.8M | 24.79 | |
| Aerie Pharmaceuticals | 33.0 | $81M | 1.7M | 48.60 | |
| Epizyme | 11.9 | $29M | 1.5M | 19.05 | |
| Alder Biopharmaceuticals | 5.2 | $13M | 1.0M | 12.25 | |
| Insmed (INSM) | 3.8 | $9.4M | 300k | 31.21 | |
| Acceleron Pharma | 3.7 | $9.1M | 245k | 37.32 | |
| Juno Therapeutics | 1.6 | $4.0M | 90k | 44.86 | |
| Jounce Therapeutics | 0.8 | $1.9M | 120k | 15.58 | |
| Dermira | 0.6 | $1.6M | 59k | 27.00 | |
| Loxo Oncology | 0.5 | $1.3M | 14k | 92.10 | |
| Orexigen Therapeutics | 0.5 | $1.1M | 523k | 2.12 | |
| Zafgen | 0.0 | $108k | 31k | 3.51 |
